H. Shi

发表

Eplerenone in patients with systolic heart failure and mild symptoms.

J. McMurray, K. Swedberg, S. Pocock, 2011, The New England journal of medicine.

Safety and efficacy of eplerenone in patients at high risk for hyperkalemia and/or worsening renal function: analyses of the EMPHASIS-HF study subgroups (Eplerenone in Mild Patients Hospitalization And SurvIval Study in Heart Failure).

J. McMurray, K. Swedberg, S. Pocock, 2013, Journal of the American College of Cardiology.

Eplerenone and new‐onset diabetes in patients with mild heart failure: results from the Eplerenone in Mild Patients Hospitalization and Survival Study in Heart Failure (EMPHASIS‐HF)

J. McMurray, D. J. Veldhuisen, K. Swedberg, 2012, European journal of heart failure.

Eplerenone and atrial fibrillation in mild systolic heart failure: results from the EMPHASIS-HF (Eplerenone in Mild Patients Hospitalization And SurvIval Study in Heart Failure) study.

J. McMurray, K. Swedberg, H. Krum, 2012, Journal of the American College of Cardiology.

SAFETY AND EFFICACY OF EPLERENONE IN PATIENTS AT HIGH RISK FOR HYPERKALEMIA AND/OR WORSENING RENAL FUNCTION. ANALYSES OF THE EMPHASIS-HF STUDY SUBGROUPS (EPLERENONE IN MILD PATIENTS HOSPITALIZATION AND SURVIVAL STUDY IN HEART FAILURE)

J. McMurray, K. Swedberg, S. Pocock, 2014 .

Eplerenone in patients with systolic heart failure and mild symptoms.

J. McMurray, K. Swedberg, S. Pocock, 2011, The New England journal of medicine.

J. McMurray, K. Swedberg, S. Pocock, 2013, Journal of the American College of Cardiology.

Eplerenone in Patients With Acute Myocardial Infarction

A. Parkhomenko, H. Krum, F. Zannad, 2008 .

Effect of Antihypertensive Agents on Cardiovascular Events in Patients With Coronary Disease and Normal Blood Pressure The CAMELOT Study: A Randomized Controlled Trial

P. Libby, E. Topol, E. Tuzcu, 2004 .

Amlodipine/Atorvastatin Single‐Pill Therapy for Blood Pressure and Lipid Goals in African Americans: Influence of the Metabolic Syndrome and Type 2 Diabetes Mellitus

K. Watson, M. Jamieson, K. Ferdinand, 2009, Journal of clinical hypertension.

Amlodipine Added to Quinapril vs Quinapril Alone for the Treatment of Hypertension in Diabetes: The Amlodipine in Diabetes (ANDI) Trial

K. Kawecka-Jaszcz, F. Zannad, R. Patni, 2007, Journal of clinical hypertension.

Effect of antihypertensive agents on cardiovascular events in patients with coronary disease and normal blood pressure: the CAMELOT study: a randomized controlled trial.

Eric J Topol, Peter Libby, P. Libby, 2004, JAMA.

Rationale and design of the Eplerenone in Mild Patients Hospitalization And SurvIval Study in Heart Failure (EMPHASIS‐HF)

J. McMurray, D. J. Veldhuisen, K. Swedberg, 2010, European journal of heart failure.

Early eplerenone treatment in patients with acute ST-elevation myocardial infarction without heart failure: the Randomized Double-Blind Reminder Study.

M. Flather, B. Pitt, F. Zannad, 2014, European heart journal.

Analysis of Disease Activity Metrics in a Methotrexate Withdrawal Study among Patients with Rheumatoid Arthritis Treated with Tofacitinib plus Methotrexate

B. Haraoui, K. Lee, M. Buch, 2022, Rheumatology and Therapy.

Improved attainment of blood pressure and cholesterol goals using single-pill amlodipine/atorvastatin in African Americans: the CAPABLE trial.

K. Watson, M. Jamieson, K. Ferdinand, 2008, Mayo Clinic proceedings.

Impact of eplerenone on cardiovascular outcomes in heart failure patients with hypokalaemia

S. Solomon, J. McMurray, K. Swedberg, 2017, European journal of heart failure.

The impact of eplerenone at different levels of risk in patients with systolic heart failure and mild symptoms: insight from a novel risk score for prognosis derived from the EMPHASIS-HF trial.

J. McMurray, K. Swedberg, S. Pocock, 2013, European heart journal.

Clinical Benefit of Eplerenone in Patients With Mild Symptoms of Systolic Heart Failure Already Receiving Optimal Best Practice Background Drug Therapy: Analysis of the EMPHASIS-HF Study

J. McMurray, K. Swedberg, S. Pocock, 2013, Circulation. Heart failure.

Eplerenone and new‐onset diabetes in patients with mild heart failure: results from the Eplerenone in Mild Patients Hospitalization and Survival Study in Heart Failure (EMPHASIS‐HF)

J. McMurray, D. J. Veldhuisen, K. Swedberg, 2012, European journal of heart failure.

Eplerenone in Patients With Systolic Heart Failure and Mild Symptoms: Analysis of Repeat Hospitalizations

J. McMurray, K. Swedberg, S. Pocock, 2012, Circulation.

Eplerenone in patients with systolic heart failure and mild symptoms: Analysis of repeat hospitalizations.

D. J. Veldhuisen, K. Swedberg, J. McMurray, 2015 .

Eplerenone in Patients with Systolic Heart Failure and Mild Symptoms : Analysis of Repeat Hospitalizations

J. McMurray, D. J. Veldhuisen, K. Swedberg, 2012 .

History of Hypertension and Eplerenone in Patients With Acute Myocardial Infarction Complicated by Heart Failure

A. Parkhomenko, H. Krum, B. Pitt, 2008, Hypertension.

Efficacy and safety of ertugliflozin in patients with type 2 diabetes mellitus and established cardiovascular disease using insulin: A VERTIS CV substudy

I. Lingvay, Jie Liu, I. Gantz, 2021, Diabetes, obesity & metabolism.

Effect of ertugliflozin on glucose control, body weight, blood pressure and bone density in type 2 diabetes mellitus inadequately controlled on metformin monotherapy (VERTIS MET)

J. Rosenstock, B. Charbonnel, J. Frias, 2018, Diabetes, obesity & metabolism.

Breast density changes in a randomized controlled trial evaluating bazedoxifene/conjugated estrogens

A. Chines, E. Baracat, J. Harvey, 2012, Menopause.

Associations between Patient Global Assessment scores and pain, physical function, and fatigue in rheumatoid arthritis: a post hoc analysis of data from phase 3 trials of tofacitinib

V. Strand, R. Alten, J. Kaine, 2020, Arthritis Research & Therapy.

The efficacy and safety of the novel aldosterone antagonist eplerenone in children with hypertension: a randomized, double-blind, dose-response study.

J. Flynn, R. Portman, M. Pressler, 2010, The Journal of pediatrics.